Page not found

Search results

  1. Taking a bite out of Charcot-Marie-Tooth Disease

    ... types of CMT that don’t involve PMP22 at all. Schwann cells, the “bodyguards” of nerve cells, wrap around nerve fibers, providing ... manager of corporate alliances for Vanderbilt’s Center for Technology Transfer and Commercialization,  attended a global conference ...

    sommers - 03/18/2024 - 1:36pm

  2. Wolbachia genetic tools for population control of harmful insects

    ... that facilitates insect range expansion.   Technology Overview Vanderbilt researchers have developed several ... sterile male offspring, is significantly more effective and stable when introduced by transgenic males than by wild-type males infected ...

    cttc_admin - 02/15/2024 - 1:30pm

  3. Vanderbilt scientists, research translation experts attend CMT Global Research Convention

    ... conference,  Margaret Read , Vanderbilt’s  Center for Technology Transfer and Commercialization  general manager for corporate ... our data and model cell line work to nervous system cells.” Since then, the CMT Research Foundation has  invested  in ...

    sommers - 10/02/2023 - 11:32am

  4. The yin and yang of cell signaling

    ... Lawrence Marnett , PhD, and colleagues used CRISPR-Cas9 technology to generate stable knock-outs of LYPLA1 and/or LYPLA2 in mouse neuroblastoma cell lines. ...

    sommers - 02/21/2019 - 9:51am

  5. Spinach protein and blackberry dye give juice to biohybrid solar cells

    ... increasing the voltage of spinach-derived biohybrid solar cells developed by Vanderbilt researchers by up to a factor of 20. The ... near that of today’s silicon solar cells. Biohybrid technology is at an early stage, comparable to silicon solar cells of 30 to 40 ...

    sommers - 03/05/2018 - 8:49am

  6. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... 16 other important protein markers found expressed in tumor cells and surrounding immune cells wherein immunotherapy treatments can be ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm

  7. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... a technique to enhance immune cell activation by exposing cells to mechanical force while culturing. Proof-of-concept data indicate that ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ...

    cttc_admin - 01/18/2024 - 9:10am

  8. HEK293 Cell Line with Stable Expression of Drosophila Serotonin Re-Uptake Transporter

    This research targets SERT. ...

    cttc_admin - 09/22/2015 - 12:24pm

  9. From Concept to Commercialization: Dr. Paul Yock

    ... for Biodesign, dedicated to advanced training in medical technology innovation. Join us for an open discussion with Dr. Yock on biodesign, medical technology innovation, and his entrepreneurial journey. Registration is ...

    sommers - 03/25/2024 - 3:02pm

  10. ThermoFisher Scientific - Research Interest Areas

    ... analysis of recombinant protein quality; rapid bioburden technology; bioprocess data analytics; technologies for new biotherapeutic ... culture and cryo-preservation media for immune and stem cells; novel characterization assays and analytics Food safety and ...

    cttc_admin - 01/30/2024 - 12:26pm